Methylphenidate, cognition, and epilepsy: A 1-month open-label trial
Epilepsia Oct 12, 2017
Adams J, et al. - This study was performed to test the hypothesis that in adults with epilepsy, methylphenidate could safely improve cognition. For improving cognition and quality of life in epilepsy, methylphenidate could be an effective and safe option. Larger and longer double-blind, placebo-controlled clinical trials were required.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
